PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 136 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $148,000 | -78.5% | 17,582 | -77.7% | 0.01% | -47.1% |
| Q4 2019 | $689,000 | +282.8% | 78,688 | +454.1% | 0.02% | +183.3% |
| Q2 2019 | $180,000 | -53.6% | 14,200 | +42.0% | 0.01% | -53.8% |
| Q1 2019 | $388,000 | -53.1% | 10,000 | -75.4% | 0.01% | -59.4% |
| Q4 2018 | $827,000 | +240.3% | 40,654 | +667.1% | 0.03% | +190.9% |
| Q3 2018 | $243,000 | +17.4% | 5,300 | +51.4% | 0.01% | 0.0% |
| Q2 2018 | $207,000 | -89.4% | 3,500 | -78.6% | 0.01% | -93.9% |
| Q3 2017 | $1,960,000 | +580.6% | 16,365 | +395.9% | 0.18% | +496.7% |
| Q2 2017 | $288,000 | -76.9% | 3,300 | -82.3% | 0.03% | -85.8% |
| Q3 2016 | $1,247,000 | – | 18,596 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |